Growth Metrics

Boston Scientific (BSX) Work In Process (2016 - 2026)

Boston Scientific's Work In Process history spans 18 years, with the latest figure at $259.0 million for Q1 2026.

  • On a quarterly basis, Work In Process rose 18.81% to $259.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $259.0 million, a 18.81% increase, with the full-year FY2025 number at $246.0 million, up 27.46% from a year prior.
  • Work In Process hit $259.0 million in Q1 2026 for Boston Scientific, up from $246.0 million in the prior quarter.
  • Over the last five years, Work In Process for BSX hit a ceiling of $259.0 million in Q1 2026 and a floor of $142.0 million in Q1 2022.
  • Historically, Work In Process has averaged $192.2 million across 5 years, with a median of $188.0 million in 2024.
  • Biggest five-year swings in Work In Process: grew 6.82% in 2024 and later grew 27.46% in 2025.
  • Tracing BSX's Work In Process over 5 years: stood at $147.0 million in 2022, then increased by 18.37% to $174.0 million in 2023, then increased by 10.92% to $193.0 million in 2024, then grew by 27.46% to $246.0 million in 2025, then grew by 5.28% to $259.0 million in 2026.
  • Business Quant data shows Work In Process for BSX at $259.0 million in Q1 2026, $246.0 million in Q4 2025, and $245.0 million in Q3 2025.